Patent details

EP1667991 Title: QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS

Basic Information

Publication number:
EP1667991
PCT Application Number:
PCT/GB/2004/003923
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047684691
PCT Publication Number:
WO/2005/026150
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS
French Title of Invention:
DERIVES DE QUINAZOLINE UTILISES COMME INHIBITEURS DE LA TYROSINE KINASE
German Title of Invention:
CHINAZOLINDERIVATE ALS TYROSINKINASEINHIBITOREN
SPC Number:

Dates

Filing date:
13/09/2004
Grant date:
14/05/2008
EP Publication Date:
14/05/2008
PCT Publication Date:
24/03/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/06/2006
EP B1 Publication Date:
14/05/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/09/2010
Expiration date:
13/09/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/09/2004
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
20/06/2008
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

1

Name:
HENNEQUIN Laurent Francois Andre
Address:
France (FR)

2

Name:
HALSALL Christopher Thomas
Address:
United Kingdom (GB)

Priority

1

Priority Number:
0321620
Priority Date:
16/09/2003
Priority Country:
United Kingdom (GB)

2

Priority Number:
0406163
Priority Date:
19/03/2004
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07D 401/12;
Filing date Document type Number of pages